Black Rock Inc. Cabaletta Bio, Inc. Transaction History
Black Rock Inc.
- $4.35 Trillion
- Q2 2024
A detailed history of Black Rock Inc. transactions in Cabaletta Bio, Inc. stock. As of the latest transaction made, Black Rock Inc. holds 4,756,219 shares of CABA stock, worth $18.8 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
4,756,219
Previous 4,057,113
17.23%
Holding current value
$18.8 Million
Previous $69.2 Million
48.6%
% of portfolio
0.0%
Previous 0.0%
Shares
13 transactions
Others Institutions Holding CABA
# of Institutions
127Shares Held
48MCall Options Held
202KPut Options Held
110K-
Jennison Associates LLC5.63MShares$22.3 Million0.02% of portfolio
-
Fred Alger Management, LLC New York, NY4.12MShares$16.3 Million0.1% of portfolio
-
T. Rowe Price Investment Management, Inc. Baltimore, MD3.67MShares$14.5 Million0.01% of portfolio
-
Adage Capital Partners Gp, L.L.C. Boston, MA3.04MShares$12 Million0.03% of portfolio
-
Bain Capital Life Sciences Investors, LLC Boston, MA2.76MShares$10.9 Million2.34% of portfolio
About Cabaletta Bio, Inc.
- Ticker CABA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 29,014,000
- Market Cap $115M
- Description
- Cabaletta Bio, Inc., a clinical-stage biotechnology company, focuses on the discovery and development of engineered T cell therapies for patients with B cell-mediated autoimmune diseases. Its proprietary technology utilizes chimeric autoantibody receptor (CAAR) T cells that are designed to selectively bind and eliminate B cells, which produce di...